A subsequent study found that the risk genotype of rs2596542, in conjunction with serum MICA levels, predicts HCC development among cirrhotic HCV-infected patients who did not achieve SVR after interferon-based treatment [93]. This evidence concerns the gene MICA and hepatocellular carcinoma.